Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: A mechanism for functional single-nucleotide polymorphisms related to phenotypes

American Journal of Human Genetics

Volumn 81, Issue 2, 2007, Pages 405-413

  Sethupathy, Praveen ^a   Borel, Christelle ^c   Gagnebin, Maryline ^c   Grant, Gregory R ^a   Deutsch, Samuel ^c   Elton, Terry S ^d   Hatzigeorgiou, Artemis G ^a,b,e   Antonarakis, Stylianos E ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^d OHIO STATE UNIVERSITY   (United States)

^e BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

3' UNTRANSLATED REGION; AGTR1 GENE; ARTICLE; BASE PAIRING; CHROMOSOME 21; DNA POLYMORPHISM; GENE; GENE EXPRESSION REGULATION; GENE MAPPING; GENE OVEREXPRESSION; HUMAN; HYPERTENSION; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRISOMY 21;

ANIMALIA;

EID: 34547727263     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/519979     Document Type: Article

References (68)

1. Kloosterman WP, Plasterk RH (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11:441-450
2. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, et al (2005) Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310:317-320
3. Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibe B, Bouix J, Caiment F, Elsen JM, Eychenne F, et al (2006) A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 38:813-818
4. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20
5. Krek A, Gruen D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al (2005) Combinatorial microRNA target predictions. Nature Genetics 37:495-500
6. Kiriakidou M, Nelson PT, Kouranov A, Fitziev P, Bouyioykos C, Mourelatos Z, Hatzigeorgiou AG (2004) A combined computational-experimental approach predicts human microRNA targets. Genes Dev 18:1165-1178
7. Brennecke J, Stark A, Russell RB, Cohen SM (2005) Principles of microRNA-target recognition. PLoS Biol 3:e85
8. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M, Greenberg ME (2006) A brain-specific microRNA regulates dendritic spine development. Nature 439:283-289
9. Lall S, Grun D, Krek A, Chen K, Wang YL, Dewey CN, Sood P, Colombo T, Bray N, MacMenamin P, et al (2006) A genomewide map of conserved microRNA targets in C. elegans. Curr Biol 16:460-471
10. Chen K, Rajewsky N (2006) Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet 38:1452-1456
11. Saunders MA, Liang H, Wen-Hsuing L (2007) Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 104:3300-3305
12. Sethupathy P, Megraw M, Hatzigeorgiou AG (2006) A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods 3:881-886
13. Rajewsky N (2006) microRNA target predictions in animals. Nat Genet 38:S8-S13
14. Sethupathy P, Corda B, Hatzigeorgiou AG (2006) TarBase: a comprehensive database of experimentally supported animal microRNA targets. RNA 12:192-197
15. Martin MM, Lee EJ, Buckenberger JA, Schmittgen TD, Elton TS (2006) MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem 281:18277-18284
16. Morrison RA, McGrath A, Davidson G, Brown JJ, Murray GD, Lever AF (1996) Low blood pressure in Down's syndrome: a link with Alzheimer's disease? Hypertension 28:569-575
17. Draheim CC, McCubbin JA, Williams DP (2002) Differences in cardiovascular disease risk between nondiabetic adults with mental retardation with and without Down syndrome. Am J Ment Retard 107:201-211
18. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Spelman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034
19. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmidt C, Bronson RT, Davisson MT (1995) A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 11:177-184
20. Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S (2004) Chromosome 21 and Down syndrome: from genomics to pathophysiology. Nat Rev Genet 5:725-738
21. Ono K, Mannami T, Baba S, Yasui N, Ogihara T, Iwai N (2003) Lack of association between angiotensin II type 1 receptor gene polymorphism and hypertension in Japanese. Hypertens Res 26:131-134
22. Takami S, Katsuya T, Rakugi H, Sato N, Nakata Y, Kamitani A, Miki T, Higaki J, Ogihara T (1998) Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. Am J Hypertens 11:316-321
23. Sugimoto K, Katsuya T, Ohkubo T, Hozawa A, Yamamoto K, Matsuo A, Rakugi H, Tsuji I, Imai Y, Ogihara T (2004) Association between angiotensin II type 1 receptor gene polymorphism and essential hypertension: the Ohasama Study. Hypertens Res 27:551-556
24. Kato N, Sugiyama T, Morita H, Kurihara H, Furukawa T, Isshiki T, Sato T, Yamori Y, Yazaki Y (2000) Comprehensive analysis of the renin-angiotensin gene polymorphisms with relation to hypertension in the Japanese. J Hypertens 18:1025-1032
25. Katsuya T, Higaki J, Ishikawa K, Sato N, Ogihara T (1999) Genetic analysis of candidate gene polymorphisms in elderly hypertension. Nippon Ronen Igakkai Zasshi 36:547-552
26. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F (1994) Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24:63-69
27. Reich H, Duncan JA, Weinstein J, Cattran DC, Scholey JW, Miller JA (2003) Interactions between gender and the angiotensin type 1 receptor gene polymorphism. Kidney Int 63: 1443-1449
28. Castellano M, Muiesan ML, Beschi M, Rizzoni D, Cinelli A, Salvetti M, Pasini G, Ported E, Bettoni G, Zulli R, et al (1996) Angiotensin II type 1 receptor A/C1166 polymorphism relationships with blood pressure and cardiovascular structure. Hypertension 28:1076-1080
29. Schmidt S, Beige J, Walla-Friedel M, Michel MC, Sharma AM, Ritz E (1997) A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension. J Hypertens 15:1385-1388
30. Thomas GN, Tomlinson B, Chan JC, Sanderson JE, Cockram CS, Critchley JA (2001) Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of the ACE insertion/deletion polymorphism with type 2 diabetes. Diabetes Care 24:356-361
31. Thomas GN, Young RP, Tomlinson B, Woo KS, Sanderson JE, Critchley JA (2000) Renin-angiotensin-aldosterone system gene polymorphisms and hypertension in Hong Kong Chinese. Clin Exp Hypertens 22:87-97
32. Zhu S, Meng QH (2006) Association of angiotensin II type 1 receptor gene polymorphism with carotid atherosclerosis. Clin Chem Lab Med 44:282-284
33. Barbalic M, Skaric-Juric T, Cambien F, Barbaux S, Poirier O, Turek S, Vrhovski-Hebrang D, Cubrilo-Turek M, Rudan I, Rudan P, et al (2006) Gene polymorphisms of the renin-angiotensin system and early development of hypertension. Am J Hypertens 19:837-842
34. Kaidashev IP, Rasin MS, Savchenko LG, Shlykova OA, Iakimishina LI (2005) Clinical efficiency of candesatran depends on angiotension II receptor, type 1 gene polymorphism. Lik Sprava 8:66-71
35. Zhang KX, Liu TB, Xu QX, Zhu DL, Huang W (2005) Association of angiotensin II receptor type 1 gene single nucleotide polymorphism with Chinese essential hypertension complicated with coronary heart disease. Zhonghua Xin Xue Guan Bing Za Zhi 33:720-723
36. Spiering W, Zwaan IM, Kroon AA, de Leeuw PW (2005) Genetic influences on 24 h blood pressure profiles in a hypertensive population: role of the angiotensin-converting enzyme insertion/deletion and angiotensin II type 1 receptor A1166C gene polymorphisms. Blood Press Monit 10:135-141
37. Abdollahi MR, Gaunt TR, Syddall HE, Cooper C, Phillips DI, Ye S, Day IN (2005) Angiotensin II type I receptor gene polymorphism: anthropometric and metabolic syndrome traits. J Med Genet 42:396-401
38. Henskens LH, Spiering W, Stoffers HE, Soomers FL, Vlietinck RF, de Leeuw PW, Kroon AA (2003) Effects of ACE I/D and AT1R-A1166C polymorphisms on blood pressure in a healthy normotensive primary care population: first results of the Hippocates study. J Hypertens 21:81-86
39. Gardier S, Vincent M, Lantelme P, Rial MO, Bricca G, Milon H (2004) A1166C polymorphism of angiotensin II type 1 receptor, blood pressure and arterial stiffness in hypertension. J Hypertens 22:2135-2142
40. Kobashi G, Hata A, Ohta K, Yamada H, Kato EH, Minakami H, Fujimoto S, Kondo K (2004) A1166C variant of angiotensin II type 1 receptor gene is associated with severe hypertension in pregnancy independently of T235 variant of angiotensinogen gene. J Hum Genet 49:182-186 (http://www.springerlink.com/ content/9tgdfpqexvxgpkmj/fulltext.html) (electronically published March 23, 2004; accessed June 29, 2007)
41. Agachan B, Isbir T, Yilmaz H, Akoglu E (2003) Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients. Exp Mol Med 35:545-549
42. Liu Y, Shan GL, Cui CY, Hou SQ, Zhuoma C, Cen WJ, Cai D, Zheng HQ, Xiao ZS, Wu ZL, Zhou WY, Qiu CC (2003) A1166C polymorphism of the angiotensin II type 1 receptor gene and essential hypertension in Han, Tibetan and Yi populations. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20:220-224
43. Porto PI, Garcia SI, Dieuzeide G, Gonzalez C, Pirola CJ (2003) Renin-angiotensin-aldosterone system loci and multilocus interactions in young-onset essential hypertension. Clin Exp Hypertens 25:117-130
44. Petrovic D, Bidovec M, Peterlin B (2002) Gene polymorphisms of the renin-angiotensin-aldosterone system and essential arterial hypertension in childhood. Folia Biol (Krakow) 50:53-56
45. Stankovic A, Zivkovic M, Glisic S, Alavantic D (2003) Angiotensin II type 1 receptor gene polymorphism and essential hypertension in Serbian population. Clin Chim Acta 327: 181-185
46. Hindorff LA, Heckbert SR, Tracy R, Tang Z, Psaty BM, Edwards KL, Siscovick DS, Kronmal RA, Nazar-Stewart V (2002) Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events. Am J Hypertens 15:1050-1056
47. Jiang Z, Zhao W, Yu F, Xu G (2001) Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Chin Med J (Engl) 114:1249-1251
48. Giner V, Corella D, Chaves FJ, Pascual JM, Portoles O, Marin P, Lozano JV, Armengod ME, Redon J (2001) Renin-angiotensin system genetic polymorphisms and essential hypertension in the Spanish population. Med Clin (Barc) 117:525-529
49. Dzida G, Sobstyl J, Puzniak A, Golon P, Mosiewicz J, Hanzlik J (2001) Polymorphisms of angiotensin-converting enzyme and angiotensin II receptor type 1 genes in essential hypertension in a Polish population. Med Sci Monit 7:1236-1241
50. Davis D, Liyou N, Johnson A (2001) The ACE gene I/D polymorphism, but not the angiotensin II type I receptor gene A1166C polymorphism is associated with isolated systolic hypertension. J Hum Hypertens 15:653-654
51. Li X, Wang L, Han X (2001) Association between angiotensin system gene polymorphism and essential hypertension. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18:292-295
52. Xiang K, Zheng T, Sun D, Li J (1998) The relationship between angiotensin II type 1 receptor gene and coronary heart disease, hypertension and diabetes mellitus in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 15:9-12
53. Nalogowska-Glosnicka K, Lacka BI, Zychma MJ, Grzeszczak W, Zukowska-Szczechowska E, Poreba R, Michalski B, Kniazewski B, Rzempoluch J (2000) Angiotensin II type 1 receptor gene A1166C polymorphism is associated with the increased risk of pregnancy-induced hypertension. Med Sci Monit 6: 523-529
54. Seremak-Mrozikiewicz A, Drews K, Chmara E, Mrozikiewicz PM, Slomko Z (2000) Gestational hypertension (GH) and a1166c polymorphism of angiotensin II type 1 receptor. Ginekol Pol 71:783-788
55. Liyou N, Davis D, James K, Simons L, Friedlander Y, Simons J, McCallum J, Johnson A (1999) The A1166C mutation in the angiotensin II type I receptor and hypertension in the elderly. Clin Exp Pharmacol Physiol 26:525-526
56. Berge KE, Berg K (1998) Polymorphisms at the angiotensin-ogen (AGT) and angiotensin II type 1 receptor (AT1R) loci and normal blood pressure. Clin Genet 53:214-219
57. Tiret L, Blanc H, Ruidavets JB, Arveiler D, Luc G, Jeunemaitre X, Tichet J, Mallet C, Poirier O, Plouin PF, Cambien F (1998) Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. J Hypertens 16:37-44
58. Wang WY, Zee RY, Morris BJ (1997) Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet 51:31-34
59. Kainulainen K, Perola M, Terwilliger J, Kaprio J, Koskenvuo M, Syvanen A, Vartiainen E, Peltonen L, Kontula K (1999) Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 33:844-849
60. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002) A comprehensive review of genetic association studies. Genet Med 4:45-61
61. van Geel PP, Pinto YM, Voors AA, Buikema H, Oosterga M, Crijns HJ, van Gilst WH (2000) Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 35:717-721
62. Carswell CI, Goa KL (2003) Losartan in diabetic nephropathy. Drugs 63:407-414
63. Song JC, White CM (2002) Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet 41:207-224
64. Burnier M, Brunner HR (2000) Angiotensin II receptor antagonists. Lancet 355:637-645
65. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34:D140-D144
66. Berezikov E, Thuemmler F, van Laake LW, Kondova I, Bontrop R, Cuppen E, Plasterk RH (2006) Diversity of microRNAs in human and chimpanzee brain. Nat Genet 38:1375-1377
67. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E (2005) Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120: 21-24
68. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einat U, Meiri E, et al (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37:766-770